Amid the concerns regarding availability of COVAXIN doses, Bharat Biotech on Friday said the timeline for manufacturing, testing and release for each batch is 4 months approximately. Production scale-up of vaccines is a step-by-step process, involving several regulatory SOPs of GMP (Standard Operating Procedures of Good Manufacturing Practices), Bharat Biotech said. Production of COVAXIN will be doubled in May-JuneMeanwhile, the Centre on Friday announced that the production of Bharat Biotech's COVAXIN will be doubled in May-June, news agency ANI reported. It added, from 1 crore vaccines in April, it will be 6 to 7 crore vaccines in July and August. Some unfound reports on unaccounted vaccine doses of Bharat Biotech having 6 crore doses is an error of comprehension.

Source: Mint May 28, 2021 12:51 UTC